Abstract

Caffeic acid (CA) is a phenolic compound synthesized by all plant species and is present in foods such as coffee, wine, tea, and popular medicines such as propolis. This phenolic acid and its derivatives have antioxidant, anti-inflammatory and anticarcinogenic activity. In vitro and in vivo studies have demonstrated the anticarcinogenic activity of this compound against an important type of cancer, hepatocarcinoma (HCC), considered to be of high incidence, highly aggressive and causing considerable mortality across the world. The anticancer properties of CA are associated with its antioxidant and pro-oxidant capacity, attributed to its chemical structure that has free phenolic hydroxyls, the number and position of OH in the catechol group and the double bond in the carbonic chain. Pharmacokinetic studies indicate that this compound is hydrolyzed by the microflora of colonies and metabolized mainly in the intestinal mucosa through phase II enzymes, submitted to conjugation and methylation processes, forming sulphated, glucuronic and/or methylated conjugates by the action of sulfotransferases, UDP-glucotransferases, and o-methyltransferases, respectively. The transmembrane flux of CA in intestinal cells occurs through active transport mediated by monocarboxylic acid carriers. CA can act by preventing the production of ROS (reactive oxygen species), inducing DNA oxidation of cancer cells, as well as reducing tumor cell angiogenesis, blocking STATS (transcription factor and signal translation 3) and suppression of MMP2 and MMP-9 (collagen IV metalloproteases). Thus, this review provides an overview of the chemical and pharmacological parameters of CA and its derivatives, demonstrating its mechanism of action and pharmacokinetic aspects, as well as a critical analysis of its action in the fight against hepatocarcinoma.

Highlights

  • Caffeic acid (CA) is a polyphenol produced through the secondary metabolism of vegetables, [1,2,3,4] including olives, coffee beans, fruits, potatoes, carrots and propolis, and constitutes the main hydroxycinnamic acid found in the diet of humans [1, 3,4,5]

  • The anticancer activity of CA seems to be associated with its potent antioxidant and prooxidant activity attributed to its chemical structure with free phenolic hydroxyls, the number and position of OH in the catechol group and the double bond in the carbonic chain

  • Caution is required in therapies with natural products, as CA and resveratrol, due to the lack of studies have addressed the efficacy of CA in hepatocarcinoma in humans and animals model, making it difficult to obtain concrete evidence of the effect of this antioxidant

Read more

Summary

INTRODUCTION

Caffeic acid (CA) is a polyphenol produced through the secondary metabolism of vegetables, [1,2,3,4] including olives, coffee beans, fruits, potatoes, carrots and propolis, and constitutes the main hydroxycinnamic acid found in the diet of humans [1, 3,4,5]. In vitro and in vivo experiments have been performed, proving innumerable physiological effects of CA and its derivatives, such as antibacterial activity [1, 4], antiviral activity [2, 5, 8, 9], antioxidant activity [2, 4, 5, 8, 9], anti-inflammatory activity [2, 4, 5, 8, 9], anti-atherosclerotic activity [1, 4], immunostimulatory activity [1, 10], antidiabetic activity [5, 9], cardioprotective activity [5, 11], antiproliferative activity [1, 12, 13], hepatoprotective activity [14, 15], anticancer activity [2, 4, 5, 8, 9], and anti-hepatocellular carcinoma activity [16,17,18] Among these properties, anti-hepatocarcinoma activity is highlighted, because hepatocarcinoma (HCC) is one of the main causes of cancer mortality in the world [19]. This review provides an overview of the chemical and pharmacological parameters of CA and its derivatives, reporting its main mechanisms of action and pharmacokinetic aspects, as well as to critically analyse its performance in the fight against HCC

CHEMICAL ASPECTS OF CAFFEIC ACID
PHARMACOKINETICS OF CAFFEIC ACID
ANTICARCINOGENIC PROPERTIES OF CAFFEIC ACID
Antioxidant Activity Prevents ROS
Peroxidation and DNA Damage
Vascularisation Induced by VEGF
In vitro
In vivo
CONCLUSION
Findings
AUTHOR CONTRIBUTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call